183 related articles for article (PubMed ID: 8577268)
1. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y
Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
Ota A; Tanaka-Taya K; Ueda S
Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A
J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
[TBL] [Abstract][Full Text] [Related]
4. Sensitive enzyme immunoassay of antibodies to HIV-1 p17 antigen using indirectly immobilized recombinant p17 for diagnosis of HIV-1 infection.
Ishikawa S; Hashinaka K; Hashida S; Oka S; Ishikawa E
J Clin Lab Anal; 1998; 12(6):343-50. PubMed ID: 9850185
[TBL] [Abstract][Full Text] [Related]
5. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
Ota A; Liu X; Fujio H; Sakato N; Ueda S
Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
[TBL] [Abstract][Full Text] [Related]
6. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
7. Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells.
Ota A; Bautista AN; Yadav ML; Ueda S
Hybridoma; 1999 Apr; 18(2):139-47. PubMed ID: 10380013
[TBL] [Abstract][Full Text] [Related]
8. Immune complex transfer enzyme immunoassay for antibody IgM to HIV-1 p17 antigen.
Hashida S; Ishikawa S; Nishikata I; Hashinaka K; Oka S; Ishikawa E
J Clin Lab Anal; 1998; 12(6):329-36. PubMed ID: 9850183
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
[TBL] [Abstract][Full Text] [Related]
10. Slight difference in primary amino acid sequence of p17 matrix protein of HIV-1 exerts profound influence on its antigenicity.
Taniguchi K; Tsuchie H; Kageyama S; Iwasaki M; Takagi T; Sasao F; Ueda S; Kurimura T
Arch Virol; 1998; 143(5):881-90. PubMed ID: 9645195
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of a mouse monoclonal antibody against the Gag p26 protein of human immunodeficiency virus type 2: identification of a new antigenic epitope.
Marcelino JM; Novo C; Pereira JM; Picotez F; Clemente A; Taveira N
AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1279-83. PubMed ID: 11559428
[TBL] [Abstract][Full Text] [Related]
12. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
Niedrig M; Harthus HP; Bröker M; Meloen R; Gelderblom H; Pauli G
Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the HIV-1 p17 protein cross-react with human superoxide dismutase-2.
Kato T; Suzuki J; Daimon M; Sasaki H; Ishikawa K
Biochem Biophys Res Commun; 1997 Jan; 230(1):184-7. PubMed ID: 9020042
[TBL] [Abstract][Full Text] [Related]
14. A unique monoclonal antibody that recognizes mature p17 of HIV-1 but not its precursor.
Saitoh A; Tanaka N; Nakata A; Ikuta K; Shinagawa H
Microbiol Immunol; 1992; 36(1):105-11. PubMed ID: 1584067
[TBL] [Abstract][Full Text] [Related]
15. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides.
Niedrig M; Hinkula J; Weigelt W; L'age-Stehr J; Pauli G; Rosen J; Wahren B
J Virol; 1989 Aug; 63(8):3525-8. PubMed ID: 2473220
[TBL] [Abstract][Full Text] [Related]
17. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
[TBL] [Abstract][Full Text] [Related]
18. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.
Niedrig M; Hinkula J; Harthus HP; Bröker M; Hopp L; Pauli G; Wahren B
J Virol; 1991 Aug; 65(8):4529-33. PubMed ID: 1712863
[TBL] [Abstract][Full Text] [Related]
19. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the affinity measurement of anti-HIV-1 p17 monoclonal antibody by BIAcore.
Ota A; Ueda S
Hybridoma; 1998 Oct; 17(5):471-7. PubMed ID: 9873993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
